Regulatory press release3/5/2025, 12:30 PMBBS-Bioactive Bone Substitutes Plc Apply for Delisting from Nasdaq First North
Regulatory press release2/20/2025, 7:00 PMBBS-Bioactive Bone Substitutes Plc: Financial calendar and Bankruptcy
Regulatory press release2/17/2025, 11:15 AMBBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc has been declared bankrupt
Regulatory press release2/12/2025, 3:00 PMBBS-Bioactive Bone Substitutes Plc - Insider information: BBS-Bioactive Bone Substitutes Plc Files for Bankruptcy
Regulatory press release2/10/2025, 7:00 AMBBS-Bioactive Bone Substitutes Plc: Situational information about measures to be taken to secure the company's financial situation and operations
Regulatory press release2/6/2025, 1:00 PMBBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
Regulatory press release1/31/2025, 2:30 PMBBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Regulatory press release12/18/2024, 12:00 PMCorrection: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatory press release12/18/2024, 11:00 AMBBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
Regulatory press release12/13/2024, 11:00 AMBBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
Regulatory press release12/13/2024, 7:30 AMBBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
Video12/2/2024, 2:00 PMLife Science Companies as Investments | Life Science Night Dec. 2, 2024Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.
Regulatory press release11/29/2024, 2:30 PMBBS-Bioactive Bone Substitutes Plc – Insider information: BBS updates its action plans
Regulatory press release11/29/2024, 2:20 PMBBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatory press release11/29/2024, 1:00 PMBBS-Bioactive Bone Substitutes Plc: Production Director Kimmo Tyni resigns from the Company
Regulatory press release11/26/2024, 3:00 PMBBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatory press release11/22/2024, 5:05 PMBBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
Regulatory press release11/22/2024, 5:00 PMBBS-Bioactive Bone Substitutes Plc – Insider information: BBS will start change negotiations
Regulatory press release11/14/2024, 12:00 PMBBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
Regulatory press release11/7/2024, 11:00 AMBBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd